Remove 2024 Remove Dosage Remove FDA
article thumbnail

What pharmacists should know about the new drugs approved in 2024

The Checkup by Singlecare

2024 has been a busy year for new drugs. Over 40 new medications have been approved by the FDA, giving patients more options for treating various health problems. Zelsuvmi (berdazimer) Zelsuvmi received the green light from the FDA on January 5, 2024. The dosage depends on the patient’s weight.

FDA 52
article thumbnail

Latuda generic availability, cost, and dosage

The Checkup by Singlecare

Latuda was initially approved by the Food and Drug Administration (FDA) in 2010. Generic Latuda availability In 2019, the FDA granted approval to several manufacturers to market generic Latuda in the United States. Data from the FDA finds that 91% of all prescription drugs in the United States are filled for generics.

Dosage 93
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Humira generic availability, cost, and dosage

The Checkup by Singlecare

While nonbiologic drugs are made with chemicals and have a known structure, most biologics are complex mixtures and cannot be easily identified or characterized, according to the Food & Drug Administration (FDA). Continue reading to learn more about FDA approved Humira biosimilars, which are made by various drug companies.

Dosage 97
article thumbnail

FDA allows Florida to import drugs from Canada

The Checkup by Singlecare

Food and Drug Administration (FDA) has granted the state of Florida the authority to import certain prescription drugs from Canada—an important measure to counteract soaring prescription costs. After delays that took a lawsuit to resolve, the FDA authorized the program on Jan. Adjust for quantity, dosage, and zip code.

FDA 105
article thumbnail

Do semaglutide tablets work?

The Checkup by Singlecare

In a 2024 KFF survey, one out of every eight Americans said they had taken a GLP-1 drug like semaglutide. Drug manufacturer Novo Nordisk produces it under the brand name Rybelsus , and the FDA approved it for managing blood glucose in people with Type 2 diabetes but not Type 1 diabetes. mg dose once weekly.

article thumbnail

FDA approves first biosimilars to Prolia and Xgeva

The Checkup by Singlecare

5, 2024, the U.S. Food & Drug Administration (FDA) approved Jubbonti and Wyost, the first interchangeable biosimilars to the injectable medications Prolia and Xgeva , respectively. The first interchangeable biosimilar was approved by the FDA in 2021 for Semglee , a biosimilar insulin to Lantus.

FDA 98
article thumbnail

Tirzepatide vs. semaglutide: Differences & similarities explained

The Checkup by Singlecare

Note that while there are compounded versions of tirzepatide and semaglutide , these drugs are not FDA approved. This article focuses on the five FDA-approved versions of tirzepatide and semaglutide. Tirzepatide is the active ingredient in two medications approved by the Food and Drug Administration (FDA). What is tirzepatide?